Bijkerk and colleagues show that pharmacological intervention of the lncRNA Malat1 protected against fibrosis in experimental kidney injury and preserved vascular integrity and may serve as potential treatment for chronic kidney disease. Here, MALAT1 is linked to chronic kidney disease.